Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pfizer CEO Albert Bourla earns 2025 pay bump to $27.6M
The CEO's 2025 pay was a sizeable bump over the $24.6 million he collected in 2024.
Zoey Becker
Mar 13, 2026 11:26am
Lilly shines in Q4 as peers brace for 2026 slowdown
Mar 11, 2026 3:00pm
Uniting for patients: Navigating, accessing, and affording care
Brought to you by
Patient Advocate Foundation
Orphan drug sales to surge past $400B in 2032: report
Mar 12, 2026 8:20am
Bayer found to have discredited industry after Roche row
Mar 13, 2026 11:45am
FDA signs off on GSK's Arexvy for at-risk adults ages 18-49
Mar 13, 2026 11:07am
More News
Manufacturing is key to Gilead's Yeztugo PrEP rollout: exec
Mar 13, 2026 10:33am
Patent expirations push biopharma industry toward a tougher 2026
Mar 13, 2026 9:49am
Manufactuing issues prompt FDA rejection of Hyloris antiviral
Mar 13, 2026 8:40am
Lilly, Pfizer-Sciwind, Astellas—Fierce Pharma Asia
Mar 13, 2026 8:05am